EcoDrugPlus

24-Dehydrocholesterol Reductase

Ensembl ID : ENSPNAG00000028979
Gene Symbol: DHCR24
3 Cross references
208 Possible Orthologues:

26s Protease Regulatory Subunit 4

Ensembl ID : ENSPNAG00000007845
Gene Symbol: LOC108443803
3 Cross references
291 Possible Orthologues:

26s Protease Regulatory Subunit 4-Like

Ensembl ID : ENSPNAG00000008732
Gene Symbol: LOC108428647
3 Cross references
292 Possible Orthologues:

26s Proteasome Non-Atpase Regulatory Subunit 11a

Ensembl ID : ENSPNAG00000009600
Gene Symbol: LOC108442534
3 Cross references
159 Possible Orthologues:

26s Proteasome Non-Atpase Regulatory Subunit 11b

Ensembl ID : ENSPNAG00000000922
Gene Symbol: LOC108426450
3 Cross references
215 Possible Orthologues:

26s Proteasome Non-Atpase Regulatory Subunit 13-Like

Ensembl ID : ENSPNAG00000013099
Gene Symbol: LOC108443072
3 Cross references
158 Possible Orthologues:

26s Proteasome Non-Atpase Regulatory Subunit 8-Like

Ensembl ID : ENSPNAG00000026500
Gene Symbol: LOC108413249
3 Cross references
210 Possible Orthologues:

26s Proteasome Non-Atpase Regulatory Subunit 8-Like

Ensembl ID : ENSPNAG00000026828
Gene Symbol: LOC108413250
3 Cross references
210 Possible Orthologues:

3-Hydroxy-3-Methylglutaryl-Coa Reductase

Ensembl ID : ENSPNAG00000028218
Gene Symbol: HMGCR
3 Cross references
152 Possible Orthologues:

3-Hydroxy-3-Methylglutaryl-Coenzyme A Reductase-Like

Ensembl ID : ENSPNAG00000010023
Gene Symbol: LOC108443142
3 Cross references
205 Possible Orthologues:

3-Phosphoinositide-Dependent Protein Kinase 1-Like

Ensembl ID : ENSPNAG00000001415
Gene Symbol: LOC108433157
3 Cross references
170 Possible Orthologues:

3-Phosphoinositide-Dependent Protein Kinase 1-Like

Ensembl ID : ENSPNAG00000013265
Gene Symbol: LOC108429196
3 Cross references
221 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).